The stock is at $2.29 as of this post, and up 5% in pre-market trading. The company most recently filed an 8k announcing a meeting with the FDA
[mstock id=”73007″ asset=”clvs”]
[mstock id=”73007″ asset=”clvs”]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations